| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/12/2004 | EP1417205A1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 05/12/2004 | EP1417191A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417181A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417055A2 Use of copper chelators to inhibit the inactivation of protein c |
| 05/12/2004 | EP1416986A2 Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 05/12/2004 | EP1416959A2 Liposomes prepared from the extractable lipids from a mycobacterium |
| 05/12/2004 | EP1416954A1 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 05/12/2004 | EP1416940A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 05/12/2004 | EP1416934A2 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 05/12/2004 | EP1416933A1 Substituted piperidines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1416916A1 Chitin microparticles and their medical uses |
| 05/12/2004 | EP1416885A2 Methods and devices for delivery of therapeutic capable agents with variable release profile |
| 05/12/2004 | EP1416884A2 Delivery of therapeutic capable agents |
| 05/12/2004 | EP1265903B1 Thiepino[3,2-b]dihydropyridines and related compositions and methods |
| 05/12/2004 | EP1200432B1 Amido spiropiperidines promote the release of growth hormone |
| 05/12/2004 | EP1163208B1 Caspase inhibitors and uses thereof |
| 05/12/2004 | EP1161410B1 Retinoid antagonists and use thereof |
| 05/12/2004 | EP1140835B1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 05/12/2004 | EP1114037B1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 05/12/2004 | EP1112070B1 Novel substituted triazole compounds |
| 05/12/2004 | EP1066316B1 Cinnamic acid derivatives having cell adhesion modulating activity |
| 05/12/2004 | EP0927192B1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 05/12/2004 | CN1496407A Flavonoid compound and process for producing the same |
| 05/12/2004 | CN1496369A Modified interferon beta with reduced immunogenicity |
| 05/12/2004 | CN1496368A Immunopotentiators |
| 05/12/2004 | CN1496362A Non-imidazole compounds as histamine H3 antagonists |
| 05/12/2004 | CN1496360A Imidazolidine derivatives, their preparation, and their use as antinflamatory agent |
| 05/12/2004 | CN1496348A 5-cyano-1H-indole derivatives as antagonists of interleukine-8 receptors |
| 05/12/2004 | CN1496266A Antiallergic agents |
| 05/12/2004 | CN1496257A Benzimidazole compounds for modulating igE and inhibiting cellular proliferation |
| 05/12/2004 | CN1495253A Condition culture medium containing factor for inhibiting cancer cell multiplication and its preparation method |
| 05/12/2004 | CN1495169A Pyridine-3-carboxylic acid derivative |
| 05/12/2004 | CN1494920A Soft capsule preparation containing cyclosporin |
| 05/12/2004 | CN1149215C Phenyl Yanthine derivatives |
| 05/12/2004 | CN1149204C 1-heterocycle substd. diarylamines |
| 05/12/2004 | CN1149195C 5-HTIF agonists |
| 05/12/2004 | CN1149191C Azetidine derivatives, Preparation and medicines containing them |
| 05/12/2004 | CN1149101C Green porphyrins as immunomodulators |
| 05/12/2004 | CN1149100C Room temperature storable immunoglobulin preparation for intravenous injection |
| 05/12/2004 | CN1149082C Di-and trivalent small molecule selecting protein inhibitors |
| 05/11/2004 | US6734306 N-benzenesulfonyl L-proline compounds as bradykinin antagonists |
| 05/11/2004 | US6734301 2,3,4,5-Tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds |
| 05/11/2004 | US6734295 Modified CRE recombinase gene for mammals |
| 05/11/2004 | US6734286 Interleukin-5 specific recombinant antibodies |
| 05/11/2004 | US6734284 Exhibits high affinity for the gfr alpha 3- ret receptor complex and unique subregions in its amino acid sequence |
| 05/11/2004 | US6734189 Hydroxamic and carboxylic acid derivatives |
| 05/11/2004 | US6734183 Useful as metalloproteinase inhibitor; piperazino-sulfonamide or piperidino-sulfonamide compound |
| 05/11/2004 | US6734013 Genetic engineering |
| 05/11/2004 | US6733994 Highly expressible genes |
| 05/11/2004 | US6733990 Useful for the treatment of immune, hematologic, fibrotic, hepatic, and respiratory disorders such as asthma using g-protein coupled receptors (gpcr) |
| 05/11/2004 | US6733981 Antibodies to interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| 05/11/2004 | US6733973 Diagnostic reagents for human cytomegalovirus and methods of use |
| 05/11/2004 | US6733801 Method of using fermented glycine max (L) extract for enhancing natural killer cell activity |
| 05/11/2004 | US6733754 Adjuvants for use in vaccines |
| 05/11/2004 | CA2225960C Pharmaceutical compositions |
| 05/06/2004 | WO2004037862A1 Special igy of resist allergic and its preparation |
| 05/06/2004 | WO2004037817A1 N-oxide compounds |
| 05/06/2004 | WO2004037805A1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/06/2004 | WO2004037801A1 Piperazinyl and diazapanyl benzamides and benzthioamides |
| 05/06/2004 | WO2004037288A1 Agent eleveting dendritic cell precursor level in blood |
| 05/06/2004 | WO2004037280A1 Angiogenesis inducer |
| 05/06/2004 | WO2004026822A3 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 05/06/2004 | WO2004018451A8 Pyridazinone-derivatives as pde4 inhibitors |
| 05/06/2004 | WO2004013629A3 Screening for agents suitable for treatment of leukocyte associated inflammatory diseases |
| 05/06/2004 | WO2004005334A3 Nucleic acid molecule encoding an allergen preprotein of a mite of genus dermatophagoides or euroglyphus and use thereof for protecting said allergen in plants |
| 05/06/2004 | WO2004004750A3 Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 05/06/2004 | WO2004000042A3 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 05/06/2004 | WO2003106428A8 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists |
| 05/06/2004 | WO2003105893A3 Probiotic therapies using lactobacillus reuteri |
| 05/06/2004 | WO2003104254A3 Novel derivatives of androstane and androstene with ascorbic a cid and use thereof in treating or preventing various conditions, diseases, and disorders |
| 05/06/2004 | WO2003101951A3 Triptolide derivatives for modulation of apoptosis and immunosuppression |
| 05/06/2004 | WO2003092580A3 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 05/06/2004 | WO2003051365A9 Use of compounds of the benzamide family as immunosuppressant |
| 05/06/2004 | WO2003046008A9 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma |
| 05/06/2004 | WO2003045316A9 Polynucleotide therapy |
| 05/06/2004 | WO2003022298A3 Use of a protein of the crmp family for treating diseases related to the immune system |
| 05/06/2004 | WO2003020219B1 Aerosolized decongestants for the treatment of sinusitis |
| 05/06/2004 | WO2003004467A3 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 05/06/2004 | WO2002102800A9 5-(2-aminopyrimidin-4-yl) benzisoxazoles as protein kinase inhibitors |
| 05/06/2004 | WO2002088078A3 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES |
| 05/06/2004 | WO2002022150A3 Medicament containing activated antithrombin iii |
| 05/06/2004 | WO2002020512A9 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 05/06/2004 | US20040087792 Tryptase-inhibitors |
| 05/06/2004 | US20040087791 Bis(substituted propynyl)-substituted benzenes, pyridines, pyrimidines, pyrazines, pyridines, furans and pyrroles; e.g., 3,5-bis-(3-(4-aminomethylbenzylaminocarbonyloxy)prop-1-ynyl)--1 -hydroxymethylbenzene |
| 05/06/2004 | US20040087784 Neuronal serine-threonine protein kinase |
| 05/06/2004 | US20040087778 Modified peptides as therapeutic agents |
| 05/06/2004 | US20040087765 Peptides, the production and use thereof for binding immunoglobulins |
| 05/06/2004 | US20040087662 Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment of delayed graft function |
| 05/06/2004 | US20040087654 Nitric oxide synthase inhibitor phosphate salt |
| 05/06/2004 | US20040087646 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 05/06/2004 | US20040087640 Administering by mouth; cyclooxygenase inhibitor; controlling particle size |
| 05/06/2004 | US20040087634 Antitumor agents; plant safening agents |
| 05/06/2004 | US20040087624 Analgesics; antiinflammatory agents; immunology; bone disorders; neurodegradation diseases |
| 05/06/2004 | US20040087621 N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists |
| 05/06/2004 | US20040087620 Terphenyl compounds bearing substituted amino groups |
| 05/06/2004 | US20040087604 Immunosuppressants; antiallergens |
| 05/06/2004 | US20040087590 Novel biphenyl and biphenyl-like cannabinoids |
| 05/06/2004 | US20040087574 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 05/06/2004 | US20040087555 Phosphohalohydrins, process for the production thereof and use thereof |
| 05/06/2004 | US20040087552 Pyrrolidine modulators of ccr5 chemokine receptor activity |